News & Commentary

340B and The Likely Path Forward

Despite its importance, the 340B drug discount program rarely ever goes under the Congressional spotlight.  In fact, until the June 4th House Energy & Commerce (E&C) Oversight and Investigations Subcommittee hearing, there had not been a … [Read more...]

Momentum Continues in States on Contract Pharmacy Access

In last month’s column, I wrote about a reprehensible campaign by 340B opponents to tie this critically important drug discount program to the contentious issue of immigration. A dark money campaign started to pour money into red states to try to … [Read more...]

Despite 340B Opponents’ Unprecedented Tactics, Many States Progress on Contract Pharmacy Protection Legislation

After over 30 years of working in Washington, D.C., I have become accustomed to the expression “politics ain’t beanbag.” The phrase, as the Christian Science Monitor explains, means “life is rough; get over it” to someone who receives bruising … [Read more...]

Key Takeaways from the SUSTAIN 340B Act and Things to Consider When Weighing In (Part 2)

(Part Two of a Two-Part Analysis) In February, the U.S. Senate bipartisan “Group of Six” released an eagerly anticipated discussion draft bill and a bill summary/request for more information on the most highly debated issues in the 340B program. The … [Read more...]

Key Takeaways from Senate Group of Six Draft 340B Bill (Part 1)

(Part One of a Two-Part Analysis) After reviewing comments from over 250 stakeholders, meeting with various interest groups and holding regular staff meetings, the U.S. Senate bipartisan “Group of Six” have released a highly … [Read more...]

Action on 340B Contract Pharmacies Turns to the States

As we approach the 16-month mark since we had pivotal arguments over the 340B contract pharmacy program in two federal appellate courts and Congress continues to offer no relief, a growing number of 340B providers are turning to state legislatures … [Read more...]

Hospitals Are Not the Only 340B Providers Under Scrutiny

Long-time 340B observers were surprised to see that Sen. Bill Cassidy (R-La.) has expanded his 340B investigation into community health centers. In September, Cassidy, a long-time critic of the program, launched an inquiry into hospital use of the … [Read more...]

Why the Genesis 340B Patient Definition Court Decision Could Resolve the Contract Pharmacy Impasse

In what legal experts describe as a landmark decision, the U.S. District Court for the District of South Carolina ruled Nov. 3 that the plain wording of the 340B statute does not require a covered entity to have initiated a healthcare service … [Read more...]

Whether it is 340B Policy or Keeping the Lights On, House Chaos Underscores Senate’s Importance

According to our history lessons, George Washington told Thomas Jefferson that the Senate was created to serve as a saucer to “cool” the House’s hot cup of tea. … [Read more...]

Could the States Resolve the Contract Pharmacy Impasse?

After a recent lull in the ongoing battle over whether drug manufacturers can continue to place restrictions on access to 340B discounts in the contract pharmacy setting, things are heating up at the state level. … [Read more...]